Novartis probes corruption claims in Chinese press

Swiss pharmaceutical giant Novartis announced Tuesday it has opened an internal inquiry following Chinese press accusations of corruption at its Alcon eye care division.

"Alcon does not tolerate activities that are not in compliance with the laws and regulations in the markets where we operate," Novartis said in a statement.

"When any inappropriate activities are identified, we take swift remedial action," it added.

The Chinese daily 21st Century Business Herald reported that Alcon offered bribes to doctors at more than 200 hospitals in China via an intermediary.

The paper, citing a whistleblower it called "Zorro", said Alcon offered the doctors "research funding" for completing market surveys that never took place.

Novartis said it would take swift corrective measures if any inappropriate behaviour is identified.

China is mounting a sweeping probe into foreign pharmaceutical firms, accusing some of abusing their monopoly positions to boost prices unfairly.

German Bayer confirmed Friday that Chinese authorities had visited one of its offices last month in connection with a potential case of "unfair competition".

Chinese police are also investigating Britain's GlaxoSmithKline (GSK) over allegations that employees gave bribes to sell its products.

Authorities have detained at least four GSK executives in the case, while state media have alleged the firm was responsible and not just individual employees.

French manufacturer Dumex promised on Monday to investigate allegations that its staff bribed Chinese hospital officials to provide its products to newborns.

In August, Beijing city health and corruption officials launched an investigation into allegations that staff at French pharmaceutical giant Sanofi bribed more than 500 Chinese doctors a total of about $280,000, according to state media.

add to favorites email to friend print save as pdf

Related Stories

China targets Germany's Bayer in drug price probe

Sep 13, 2013

Chinese authorities have visited an office of German pharmaceutical giant Bayer, the company said Friday, making it the latest target in a probe of foreign drug firms over high prices.

China state media raises pressure on Britain's GSK

Sep 03, 2013

Chinese state media increased the pressure on British pharmaceutical giant GlaxoSmithKline (GSK) over a bribery investigation Tuesday, accusing the firm of being responsible rather than individual employees.

China shuts travel agency in GSK bribery case

Jul 19, 2013

China has shut down a travel agency which served as a conduit for bribes allegedly given by staff of British drug firm GlaxoSmithKline (GSK), the government and state media said.

Chinese police say Glaxo employees bribed doctors

Jul 11, 2013

China's police ministry accused executives of pharmaceutical supplier GlaxoSmithKline on Thursday of conducting a large and long-running bribery campaign to persuade doctors to prescribe drugs.

Recommended for you

FDA proposes accelerated medical device approval plan

8 hours ago

(HealthDay)—The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical ...

Targeting drugs to reduce side effects

14 hours ago

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

User comments